C07H 15/23
With only two saccharide radicals in the molecule
Official title: with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
C07H15/23 (With only two saccharide radicals in the molecule) appears on 56 US grants and 38 published applications in this corpus.
Search patents in C07H- Granted patents
- 56
- Published applications
- 38
- Assignees
- 34
- Inventors
- 114
- Latest grant
- 8 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 7 | 0 |
| 1978 | 5 | 0 |
| 1979 | 4 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 3 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 1 | 2 |
| 2012 | 1 | 0 |
| 2013 | 1 | 3 |
| 2014 | 2 | 3 |
| 2015 | 2 | 1 |
| 2016 | 1 | 2 |
| 2017 | 2 | 1 |
| 2018 | 1 | 5 |
| 2019 | 1 | 3 |
| 2020 | 1 | 2 |
| 2021 | 3 | 6 |
| 2022 | 2 | 3 |
| 2023 | 4 | 4 |
| 2024 | 3 | 0 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of FimH8 Jul 2025US 12,351,597 B2Fimbrion Therapeutics, Inc.
- Modular synthesis of aminoglycosides29 Oct 2024US 12,129,274 B2Revagenix, Inc.
- Amphiphilic kanamycin compositions and methods8 Oct 2024US 12,110,310 B2Utah State University
- Aminoglycosides and uses thereof in treating genetic disorders9 Jan 2024US 11,865,128 B2Technion Research & Development Foundation Limited
- Chromatographic material having improved pH stability, method for preparation thereof and uses thereof14 Nov 2023US 11,813,588 B2Dionex Corporation
- Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of fimh12 Mar 2026US 2026/0070939 A1Fimbrion Therapeutics, Inc.
- E-selectin targeting agents16 Nov 2023US 2023/0364277 A1GlycoMimetics, Inc.
- Aminoglycoside derivatives and uses thereof in treating genetic disorders15 Jun 2023US 2023/0181612 A1
- Modular synthesis of aminoglycosides1 Jun 2023US 2023/0167148 A1Revagenix, Inc.
- Aminoglycoside derivatives and uses thereof in treating genetic disorders30 Mar 2023US 2023/0097398 A1Eloxx Pharmaceuticals Ltd.
Most cited
By later US patents
- Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents40US 7,893,039 B2Isis Pharmaceuticals, Inc. · 2011
- 3'-Epi-4'deoxykanamycin B21US 4,078,138 AMeiji Seika Kaisha, Ltd. · 1978
- Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents20US 8,114,856 B2Isis Pharmaceuticals, Inc. · 2012
- 1-N-[(S)-.alpha.-hydroxy-.omega.-aminoacyl] derivatives of 3',4'-dideoxykanamycin B and 3'-deoxykanamycin B antibiotics18US 4,107,424 AZaidan Hojin Biseibutsu Kagaku Kenkyu Kai · 1978
- Derivatives of kanamycin A17US 4,170,642 AZaidan Hojin Biseibutsu Kagaku Kenkyu Kai · 1979